Portal de Periódicos da CAPES

The Direct Interaction of Phospholipase C-γ1 with Phospholipase D2 Is Important for Epidermal Growth Factor Signaling

2003; Elsevier BV; Volume: 278; Issue: 20 Linguagem: Inglês

10.1074/jbc.m208438200

1083-351X

Il Ho Jang, Sukmook Lee, Jong Bae Park, Jong Hyun Kim, Chang Sup Lee, Eun‐Mi Hur, Il Shin Kim, Kyong‐Tai Kim, Hitoshi Yagisawa, Pann‐Ghill Suh, Sung Ho Ryu,

Glycosylation and Glycoproteins Research

The epidermal growth factor (EGF) receptor has an important role in cellular proliferation, and the enzymatic activity of phospholipase C (PLC)-γ1 is regarded to be critical for EGF-induced mitogenesis. In this study, we report for the first time a phospholipase complex composed of PLC-γ1 and phospholipase D2 (PLD2). PLC-γ1 is co-immunoprecipitated with PLD2 in COS-7 cells. The results of in vitro binding analysis and co-immunoprecipitation analysis in COS-7 cells show that the Src homology (SH) 3 domain of PLC-γ1 binds to the proline-rich motif within the Phox homology (PX) domain of PLD2. The interaction between PLC-γ1 and PLD2 is EGF stimulation-dependent and potentiates EGF-induced inositol 1,4,5-trisphosphate (IP3) formation and Ca2+increase. Mutating Pro-145 and Pro-148 within the PX domain of PLD2 to leucines disrupts the interaction between PLC-γ1 and PLD2 and fails to potentiate EGF-induced IP3 formation and Ca2+ increase. However, neither PLD2 wild type nor PLD2 mutant affects the EGF-induced tyrosine phosphorylation of PLC-γ1. These findings suggest that, upon EGF stimulation, PLC-γ1 directly interacts with PLD2 and this interaction is important for PLC-γ1 activity. The epidermal growth factor (EGF) receptor has an important role in cellular proliferation, and the enzymatic activity of phospholipase C (PLC)-γ1 is regarded to be critical for EGF-induced mitogenesis. In this study, we report for the first time a phospholipase complex composed of PLC-γ1 and phospholipase D2 (PLD2). PLC-γ1 is co-immunoprecipitated with PLD2 in COS-7 cells. The results of in vitro binding analysis and co-immunoprecipitation analysis in COS-7 cells show that the Src homology (SH) 3 domain of PLC-γ1 binds to the proline-rich motif within the Phox homology (PX) domain of PLD2. The interaction between PLC-γ1 and PLD2 is EGF stimulation-dependent and potentiates EGF-induced inositol 1,4,5-trisphosphate (IP3) formation and Ca2+increase. Mutating Pro-145 and Pro-148 within the PX domain of PLD2 to leucines disrupts the interaction between PLC-γ1 and PLD2 and fails to potentiate EGF-induced IP3 formation and Ca2+ increase. However, neither PLD2 wild type nor PLD2 mutant affects the EGF-induced tyrosine phosphorylation of PLC-γ1. These findings suggest that, upon EGF stimulation, PLC-γ1 directly interacts with PLD2 and this interaction is important for PLC-γ1 activity. epidermal growth factor phospholipase C phospholipase D phosphatidylinositol 4,5-bisphosphate inositol 1,4,5-trisphosphate protein kinase C Src homology pleckstrin homology Phox homology phosphatidic acid enhanced chemiluminescence glutathioneS-transferase The epidermal growth factor (EGF)1 signaling pathways have been implicated in cellular proliferation and cytoskeletal reorganization (1Ciardiello F. Drugs. 2000; 60: 25-32Crossref PubMed Scopus (181) Google Scholar). The enzymatic activity of phospholipase C (PLC)-γ1, a downstream signaling component of EGF, is required for the EGF-induced cellular responses (2Wang Z. Glück S. Zhang L. Morgan M.F. Mol. Cell. Biol. 1998; 18: 590-597Crossref PubMed Google Scholar, 3Pei Z.-D. Williamson J.R. FEBS Lett. 1998; 423: 53-56Crossref PubMed Scopus (11) Google Scholar, 4Yu H. Fukami K. Itoh T. Takenawa T. Exp. Cell Res. 1998; 243: 113-122Crossref PubMed Scopus (36) Google Scholar). PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2), and one product of this hydrolysis, inositol 1,4,5-trisphosphate (IP3), mobilizes Ca2+ from the intracellular stores, whereas the other product of the hydrolysis, 1,2-diacylglycerol, activates protein kinase C (PKC) (5Berridge M.J. Biochem. J. 1984; 220: 345-360Crossref PubMed Scopus (2493) Google Scholar). Until recently, 11 mammalian PLC isozymes have been identified and classified into four types (6Rhee S.G. Suh P.-G. Ryu S.H. Lee S.Y. Science. 1989; 244: 546-550Crossref PubMed Scopus (699) Google Scholar, 7Rhee S.G. Bae Y.S. J. Biol. Chem. 1997; 272: 15045-15048Abstract Full Text Full Text PDF PubMed Scopus (817) Google Scholar, 8Song C. Hu C.-D. Masago M. Kariya K.-I. Yamawaki-Kataoka Y. Shibatohge M. Wu D. Satoh T. Kataoka T. J. Biol. Chem. 2001; 276: 2752-2757Abstract Full Text Full Text PDF PubMed Scopus (281) Google Scholar). PLC-γ, unlike the other PLC isozymes, has Src homology (SH) domains: two SH2 and one SH3 domains (9Suh P.-G. Ryu S.H. Moon K.H. Suh H.W. Rhee S.G. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 5419-5423Crossref PubMed Scopus (127) Google Scholar). Tyrosine phosphorylation of PLC-γ1 by the EGF receptor is responsible for inositol phosphate production (10Rhee S.G. Trends Biochem. Sci. 1991; 16: 297-301Abstract Full Text PDF PubMed Scopus (193) Google Scholar, 11Martin T.F.J. Pharmacol. Ther. 1991; 49: 329-345Crossref PubMed Scopus (22) Google Scholar, 12Kim U.H. Kim H.S. Rhee S.G. FEBS Lett. 1990; 270: 33-36Crossref PubMed Scopus (29) Google Scholar). The SH2 domains of PLC-γ1 are important for binding to the EGF receptor and for phosphorylation by the receptor, which is required for activation (13Gergel J.R. McNamara D.J. Dobrusin E.M. Zhu G. Saltiel A.R. Miller W.T. Biochemistry. 1994; 33: 14671-14678Crossref PubMed Scopus (19) Google Scholar, 14Anderson D. Koch C.A. Grey L. Ellis C. Moran M.F. Pawson T. Science. 1990; 250: 979-982Crossref PubMed Scopus (432) Google Scholar, 15Chattopadhyay A. Vecchi M. Ji Q.-S. Mernaugh R. Carpenter G. J. Biol. Chem. 1999; 274: 26091-26097Abstract Full Text Full Text PDF PubMed Scopus (115) Google Scholar). However, little is known about how phosphorylated PLC-γ1 undergoes further processes such as targeting to its PIP2 substrate molecules in the membrane. Phospholipase D is a membrane-associated enzyme, which hydrolyzes phosphatidylcholine to generate phosphatidic acid (PA) and choline (16Frohman M.A. Sung T.C. Morris A.J. Biochim. Biophys. Acta. 1999; 1439: 175-186Crossref PubMed Scopus (277) Google Scholar). PA has been shown to be an intracellular lipid second messenger involved in many physiological events such as the promotion of mitogenesis, the secretory process, and actin cytoskeletal reorganization (17Jones D. Morgan C. Cockcroft S. Biochim. Biophys. Acta. 1999; 1439: 229-244Crossref PubMed Scopus (168) Google Scholar, 18Danniel L.W. Sciorra V.A. Ghosh S. Biochim. Biophys. Acta. 1999; 1439: 265-276Crossref PubMed Scopus (36) Google Scholar, 19Cross M.J. Roberts S. Ridley A.J. Hodgkin M.N. Stewart A. Claesson-Welsh L. Wakelam M.J.O. Curr. Biol. 1996; 6: 588-597Abstract Full Text Full Text PDF PubMed Google Scholar, 20Rizzo M.A. Shome K. Vasudevan C. Stolz D.B. Sung T.C. Frohman M.A. Watkins S.C. Romero G. J. Biol. Chem. 1999; 274: 1131-1139Abstract Full Text Full Text PDF PubMed Scopus (268) Google Scholar). PLD activity is regulated by protein kinases, small molecular weight G-proteins, and Ca2+ (21Exton J.H. Biochim. Biophys. Acta. 1999; 1439: 121-133Crossref PubMed Scopus (337) Google Scholar), and PKC has been suggested to be a major mediator of PLD stimulation (22Kim Y. Han J.M. Han B.R. Lee K.-A. Kim J.H. Lee B.D. Jang I.-H. Suh P.-G. Ryu S.H. J. Biol. Chem. 2000; 275: 13621-13627Abstract Full Text Full Text PDF PubMed Scopus (80) Google Scholar). Moreover, PLD requires PIP2 for its enzymatic activity (23Sciorra V.A. Rudge S.A. Prestwich G.D. Frohman M.A. Engebrecht J. Morris A.J. EMBO J. 1999; 18: 5911-5921Crossref PubMed Scopus (147) Google Scholar). Two types of mammalian PLD isoforms, PLD1 and PLD2, have been reported, which share 55% identity (24Kim Y. Han J.M. Park J.B. Lee S.D. Oh Y.S. Chung C. Lee T.G. Kim J.H. Park S.-K. Yoo J.-S. Suh P.-G. Ryu S.H. Biochemistry. 1999; 38: 10344-10351Crossref PubMed Scopus (69) Google Scholar). EGF stimulation increases PLD activity (25Xu L. Shen Y. Joseph T. Bryant A. Luo J.-O. Frankel P. Rotunda T. Foster D.A. Biochem. Biophys. Res. Commun. 2000; 273: 77-83Crossref PubMed Scopus (25) Google Scholar, 26Hornia A. Lu Z. Sukezane T. Zhong M. Joseph T. Frankel P. Foster D.A. Mol. Cell. Biol. 1999; 19: 7672-7680Crossref PubMed Google Scholar), but the roles of the domains of PLD in EGF signaling have not been identified. It has been reported that the EGF receptor is highly enriched in the plasma membrane substructure, caveolae (27Couet J. Sargiacomo M. Lisanti M.P. J. Biol. Chem. 1997; 272: 30429-30438Abstract Full Text Full Text PDF PubMed Scopus (549) Google Scholar, 28Pike L.J. Miller J.M. J. Biol. Chem. 1998; 273: 22298-22304Abstract Full Text Full Text PDF PubMed Scopus (348) Google Scholar), and in our previous study, we found that PLC-γ1 translocates to caveolae upon EGF stimulation (29Jang I.-H. Kim J.H. Lee B.D. Bae S.S. Park M.H. Suh P.-G. Ryu S.H. FEBS Lett. 2001; 491: 4-8Crossref PubMed Scopus (37) Google Scholar). PLD isozymes exist both in the caveolae, and the cellular distribution of PLD2, in particular, is largely restricted to caveolae (25Xu L. Shen Y. Joseph T. Bryant A. Luo J.-O. Frankel P. Rotunda T. Foster D.A. Biochem. Biophys. Res. Commun. 2000; 273: 77-83Crossref PubMed Scopus (25) Google Scholar, 30Kim J.H. Han J.M. Lee S. Kim Y. Lee T.G. Park J.B. Lee S.D. Suh P.-G. Ryu S.H. Biochemistry. 1999; 38: 3763-3769Crossref PubMed Scopus (59) Google Scholar). PIP2, the substrate of PLC-γ1 and the activator of PLD, is also highly enriched in caveolae (31Pike L.J. Casey L. J. Biol. Chem. 1996; 271: 26453-26456Abstract Full Text Full Text PDF PubMed Scopus (332) Google Scholar). The communication between PLC-γ1 and PLD has been questioned. PKC, a downstream signaling molecule of PLC-γ1, is required for PLD activation (26Hornia A. Lu Z. Sukezane T. Zhong M. Joseph T. Frankel P. Foster D.A. Mol. Cell. Biol. 1999; 19: 7672-7680Crossref PubMed Google Scholar, 32Voss M. Weernink P.A. Haupenthal S. Moler U. Cool R.H. Bauer B. Camonis J.H. Jakobs K.H. Schmidt M. J. Biol. Chem. 1999; 274: 34691-34698Abstract Full Text Full Text PDF PubMed Scopus (59) Google Scholar). Mouse embryo fibroblast lacking PLC-γ1 showed markedly reduced PLD activity (33Hess J.A. Ji Q.-S. Carpenter G. Exton J.H. J. Biol. Chem. 1998; 273: 20517-20524Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar), and PA, the product of PLD action in the membrane, increased in vitro PLC-γ1 activity (34Jones G.A. Carpenter G. J. Biol. Chem. 1993; 268: 20845-20850Abstract Full Text PDF PubMed Google Scholar). These reports suggest that the two phospholipases (PLC-γ1 and PLD2) may affect each other dynamically by changing the membrane phospholipids. Nevertheless, the direct relationship between these phospholipases in cells has not been studied. In this report, we demonstrate for the first time the direct association between two signaling phospholipases, PLC-γ1 and PLD2. We suggest that their interaction is important for the proper activation of PLC-γ1 after EGF stimulation. The enhanced chemiluminescence (ECL) kit was purchased from Amersham Biosciences (Buckinghamshire, United Kingdom); [3H]myristic acid and [3H]inositol 1,4,5-trisphosphate were obtained from PerkinElmer Life Sciences (Boston, MA); Silica Gel 60 thin-layer chromatography plates were obtained from MERK (Darmstadt, Germany); protein A-Sepharose was obtained from RepliGen (Needham, MA); Dulbecco's modified Eagle's medium and LipofectAMINE were obtained from Invitrogen (Grand Island, NY); bovine calf serum was obtained from HyClone (Logan, UT); EGF was obtained from the Daewoong Pharmaceutical Co. (Seoul, Republic of Korea); cholic acid was obtained from USB (Cleveland, OH); and horseradish peroxidase-conjugated goat anti-rabbit IgG and anti-mouse IgG, IgM, and IgA were purchased from Kirkegaard and Perry Laboratories, Inc. (Gaithersburg, MD). A polyclonal antibody (mSTP4) that recognizes both PLD1 and PLD2 was produced as described previously (35Kim J.H. Kim Y. Lee S.D. Lopez I. Arnold R.S. Lambeth J.D. Suh P.-G. Ryu S.H. FEBS Lett. 1999; 454: 42-46Crossref PubMed Scopus (83) Google Scholar). Anti-actin monoclonal antibody was purchased from ICN Pharmaceuticals (Costa Mesa, CA). Monoclonal antibodies for PLC-β1, PLC-γ1, and phosphotyrosine and DNAs of wild type human PLD2 in pCDNA3.1, wild type rat PLC-γ1 in pFLAG-CMV-2, and the SH3 domain deleted rat PLC-γ1 in pFLAG-CMV-2 were prepared as described previously (36Bae S.S. Lee Y.H. Chang J.-S. Galadari S.H. Kim Y.S. Ryu S.H. Suh P.-G. J. Neurochem. 1998; 71: 178-185Crossref PubMed Scopus (42) Google Scholar, 37Bahk Y.Y. Lee Y.H. Lee T.G. Seo J. Ryu S.H. Suh P.-G. J. Biol. Chem. 1994; 269: 8240-8245Abstract Full Text PDF PubMed Google Scholar, 38Kim M.J. Chang J.-S. Park S.K. Hwang J.-I. Ryu S.H. Suh P.-G. Biochemistry. 2000; 39: 8674-8682Crossref PubMed Scopus (50) Google Scholar, 39Lee S. Kim J.H. Lee C.S. Kim J.H. Kim Y. Heo K. Ihara Y. Goshima Y. Suh P.-G. Ryu S.H. J. Biol. Chem. 2002; 277: 6542-6549Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar, 47Ho S.N. Hunt H.D. Horton R.M. Pullen J.K. Pease L.R. Gene (Amst.). 1989; 77: 51-59Crossref PubMed Scopus (6851) Google Scholar). Full-length cDNAs of murine PLD2 and its N-terminal deletion mutant (Δ1–308) were provided generously by Dr. Michael A. Frohman (State University of New York, NY). Anti-FLAG M5 monoclonal antibody and all other chemicals were from Sigma (St. Louis, MO). COS-7 cells were cultured and transfected using LipofectAMINE (Invitrogen) as described previously (39Lee S. Kim J.H. Lee C.S. Kim J.H. Kim Y. Heo K. Ihara Y. Goshima Y. Suh P.-G. Ryu S.H. J. Biol. Chem. 2002; 277: 6542-6549Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar, 40Lee S. Park J.B. Kim J.H. Kim Y. Kim J.H. Shin K.-J. Lee J.S. Ha S.H. Suh P.-G. Ryu S.H. J. Biol. Chem. 2001; 276: 28252-28260Abstract Full Text Full Text PDF PubMed Scopus (103) Google Scholar). Recombinant rat PLC-β1, PLC-γ1, and human PLD2 were expressed in Sf9 cells and purified as described previously (41Bae S.S. Perry D.K. Oh Y.S. Choi J.H. Galadari S.H. Ghayur T. Ryu S.H. Hannun Y.A. Suh P.-G. FASEB J. 2000; 14: 1083-1092Crossref PubMed Scopus (68) Google Scholar,42Kim J.H. Lee S.D. Han J.M. Lee T.G. Kim Y. Park J.B. Lambeth J.D. Suh P.-G. Ryu S.H. FEBS Lett. 1998; 430: 231-235Crossref PubMed Scopus (89) Google Scholar). GlutathioneS-transferase (GST) fusion proteins containing the SH domains of PLC-γ1 and human PLD2 fragments were prepared as described previously (38Kim M.J. Chang J.-S. Park S.K. Hwang J.-I. Ryu S.H. Suh P.-G. Biochemistry. 2000; 39: 8674-8682Crossref PubMed Scopus (50) Google Scholar, 40Lee S. Park J.B. Kim J.H. Kim Y. Kim J.H. Shin K.-J. Lee J.S. Ha S.H. Suh P.-G. Ryu S.H. J. Biol. Chem. 2001; 276: 28252-28260Abstract Full Text Full Text PDF PubMed Scopus (103) Google Scholar, 43Kim J.H. Lee S. Kim J.H. Lee T.G. Hirata M. Suh P.-G. Ryu S.H. Biochemistry. 2002; 41: 3414-3421Crossref PubMed Scopus (69) Google Scholar). GST fusion SH3 domains of Abl and CrkI were kindly provided by Dr. Brian K. Kay (The University of Wisconsin, Madison, WI) (44Sparks A.B. Hoffman N.G. McConnell S.J. Fowlkes D.M. Kay B.K. Nat. Biotechnol. 1996; 14: 741-744Crossref PubMed Scopus (215) Google Scholar). GST fusion Phox homology (PX) domains of p40phox and p47phox were kindly provided by Dr. Michael B. Yaffe (Massachusetts Institute of Technology, MA) (45Kanai F. Liu H. Field S.J. Akbary H. Matsuo T. Brown G.E. Cantley L.C. Yaffe M.B. Nat. Cell Biol. 2001; 3: 675-678Crossref PubMed Scopus (501) Google Scholar). After harvesting the cells, the GST fusion proteins were purified by standard methods (46Lee C. Kim S.R. Chung J.K. Frohman M.A. Kilimann M.W. Rhee S.G. J. Biol. Chem. 2000; 275: 18751-18758Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar) using glutathione-Sepharose 4B (Amersham Biosciences). Proteins were denatured by boiling for 5 min at 95 °C in a Laemmli sample buffer (48Laemmli U.K. Nature. 1970; 227: 680-685Crossref PubMed Scopus (207537) Google Scholar), separated by SDS-PAGE, and immunoblot analysis was performed as described previously (39Lee S. Kim J.H. Lee C.S. Kim J.H. Kim Y. Heo K. Ihara Y. Goshima Y. Suh P.-G. Ryu S.H. J. Biol. Chem. 2002; 277: 6542-6549Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar). In vitro binding was performed in 300 μl of binding buffer (20 mm Tris/HCl, pH 8.0, 150 mm NaCl, 1 mm MgCl2, 1 mm EGTA, 0.1% Triton X-100) at 4 °C for 3 h. Cells were lysed with IP buffer (20 mm Tris/HCl, pH 8.0, 150 mm NaCl, 1 mm MgCl2, 1 mm EGTA, 1% Triton X-100, 1% cholic acid) by sonication. Cell lysates were centrifuged at 100,000 × g at 4 °C for 30 min, and the supernatants were incubated with an antibody immobilized to Protein A-Sepharose beads. Cellular IP3 concentration was determined by the [3H]IP3 competition assay using IP3 binding protein (49Suh B.C. Chae H.D. Chung J.H. Kim K.T. Br. J. Pharmacol. 1999; 126: 399-406Crossref PubMed Scopus (11) Google Scholar), which was prepared from bovine adrenal cortex as described previously (50Challiss R.A. Chilvers E.R. Willcocks A.L. Nahorski S.R. Biochem. J. 1990; 265: 421-427Crossref PubMed Scopus (127) Google Scholar). PLD activity was assayed by measuring phosphatidylbutanol formation in the presence of 1-butanol as described previously (51Kim J.H. Lee B.D. Kim Y. Lee S.D. Suh P.-G. Ryu S.H. J. Immunol. 1999; 163: 5462-5470PubMed Google Scholar). [Ca2+]ilevels were determined using Grynkiewicz et al.'s method with fura-2/AM in Ca2+-free Locke's solution (154 mm NaCl, 5.6 mm KCl, 1.2 mmMgCl2, 5 mm HEPES, pH 7.3, 10 mmglucose, and 0.2 mm EGTA) (52Grynkiewicz G. Poenie M. Tsien R.Y. J. Biol. Chem. 1985; 260: 3440-3450Abstract Full Text PDF PubMed Scopus (80) Google Scholar). It has been reported that the EGF receptor, PLD2, and PIP2 are enriched in the plasma membrane substructure, caveolae, to which PLC-γ1 translocates after EGF stimulation (25Xu L. Shen Y. Joseph T. Bryant A. Luo J.-O. Frankel P. Rotunda T. Foster D.A. Biochem. Biophys. Res. Commun. 2000; 273: 77-83Crossref PubMed Scopus (25) Google Scholar,27Couet J. Sargiacomo M. Lisanti M.P. J. Biol. Chem. 1997; 272: 30429-30438Abstract Full Text Full Text PDF PubMed Scopus (549) Google Scholar, 28Pike L.J. Miller J.M. J. Biol. Chem. 1998; 273: 22298-22304Abstract Full Text Full Text PDF PubMed Scopus (348) Google Scholar, 29Jang I.-H. Kim J.H. Lee B.D. Bae S.S. Park M.H. Suh P.-G. Ryu S.H. FEBS Lett. 2001; 491: 4-8Crossref PubMed Scopus (37) Google Scholar, 31Pike L.J. Casey L. J. Biol. Chem. 1996; 271: 26453-26456Abstract Full Text Full Text PDF PubMed Scopus (332) Google Scholar). PIP2, the substrate of PLC-γ1, was reported to be a cofactor of PLD activation (16Frohman M.A. Sung T.C. Morris A.J. Biochim. Biophys. Acta. 1999; 1439: 175-186Crossref PubMed Scopus (277) Google Scholar). We checked the possibility of the existence of PIP2-utilizing phospholipases in a complex. The major isozyme of PLD in COS-7 cells is PLD2, and PLC-γ1 was co-immunoprecipitated with PLD2 from COS-7 cells growing in media containing 10% bovine calf serum (Fig.1A). However, because the amount of PLD2 in COS-7 cells is very small, the co-immunoprecipitation could be detected after a long time exposure to a film. By transfecting PLD2 into COS-7 cells, the co-immunoprecipitation of PLC-γ1 with PLD2 was more easily detected (Fig. 1B). These results indicate that two phospholipases exist in a complex. It could be deduced from previous reports that EGF stimulation recruits PLC-γ1 from the cytosol to the plasma membrane where PLD2 is enriched (25Xu L. Shen Y. Joseph T. Bryant A. Luo J.-O. Frankel P. Rotunda T. Foster D.A. Biochem. Biophys. Res. Commun. 2000; 273: 77-83Crossref PubMed Scopus (25) Google Scholar, 29Jang I.-H. Kim J.H. Lee B.D. Bae S.S. Park M.H. Suh P.-G. Ryu S.H. FEBS Lett. 2001; 491: 4-8Crossref PubMed Scopus (37) Google Scholar). We observed that increasing the amount of PLD2 in COS-7 cells resulted in increasing EGF-induced PLC-γ1 activity, but PLD2 didn't affect PLC-γ1 activity without EGF stimulation or the time course of PLC-γ1 activity after EGF stimulation (Fig.2, A and B). We tested whether the interaction between PLC-γ1 and PLD2 is dependent on EGF stimulation. As shown in Fig. 2C, serum starvation abolishes the interaction of PLC-γ1 with PLD2, but as soon as cells were stimulated with EGF, PLC-γ1 binds to PLD2 and then dissociates from PLD2. The interaction time course correlates with the activity time course of PLC-γ1 (Fig. 2B). These results suggest that the interaction of PLC-γ1 with PLD2 may contribute to increasing EGF-induced PLC-γ1 activity. To test whether their interaction is direct or not,in vitro binding analysis was performed with purified PLC-γ1 and PLD2. Purified PLC-γ1, or PLC-β1 for comparison, was incubated with purified PLD2 and immunoprecipitated with an anti-PLD antibody. As shown in Fig. 3B, PLC-γ1, but not PLC-β1, was precipitated by PLD2. These results indicate that PLC-γ1 binds directly to PLD2. The major differences between PLC-γ1 and PLC-β1 lie in the linker region between the X and Y domains. PLC-γ1 has two SH2 domains and one SH3 domain, but PLC-β1 has no SH domain (Fig. 3A). To identify which domain of PLC-γ1 is responsible for the interaction with PLD2,in vitro binding analysis was performed with purified PLD2 and the GST fusion SH domains of PLC-γ1. As shown in Fig.3C, PLD2 bound to GST-SH223 and GST-SH3 but not to GST-SH2N or GST-SH2C. This result indicates that the SH3 domain of PLC-γ1 interacts with PLD2. For further confirmation, co-immunoprecipitation analysis was performed in cells growing in media containing 10% bovine calf serum. PLD2 was co-transfected into COS-7 cells with PLC-γ1 wild type or PLC-γ1 SH3 domain deletion mutant and immunoprecipitated with an anti-PLD antibody. As shown in Fig. 3D, PLC-γ1 wild type co-immunoprecipitated with PLD2, whereas the PLC-γ1 SH3 domain deletion mutant did not. These results indicate that the SH3 domain of PLC-γ1 is responsible for the interaction with PLD2. To identify the region of PLD2 responsible for the interaction with PLC-γ1, we constructed GST fusion PLD2 fragments as shown in Fig.4A (40Lee S. Park J.B. Kim J.H. Kim Y. Kim J.H. Shin K.-J. Lee J.S. Ha S.H. Suh P.-G. Ryu S.H. J. Biol. Chem. 2001; 276: 28252-28260Abstract Full Text Full Text PDF PubMed Scopus (103) Google Scholar). Fig. 4Bshows the result of in vitro binding analysis with purified PLC-γ1 and GST fusion PLD2 fragments. PLC-γ1 was found to bind to the F1 fragment (residues 1–314) of PLD2. For further confirmation, co-immunoprecipitation analysis was performed. COS-7 cells were transfected with the empty vector, PLD2 wild type, or the PLD2 deletion mutant (Δ1–308), and immunoprecipitated with an anti-PLD antibody. As shown in Fig. 4C, PLC-γ1 was co-immunoprecipitated with PLD2 wild type but not with the PLD2 deletion mutant (Δ1–308). These results indicate that the N-terminal 1–308 residues of PLD2 are important for interaction with PLC-γ1. To determine the binding region more precisely, we prepared four GST fusion C-terminally deleted constructs of the PLD2 F1 fragment (Fig. 4A). In vitro binding analysis with purified PLC-γ1 and each GST fusion construct showed that PLC-γ1 binds to f1, f1-1, and f1-2 but not to f1-3 or f1-4, indicating that the residues from 114 to 166 of PLD2 are responsible for the interaction (Fig. 4D). In the sequence from 114 to 166 of PLD2, there is a proline-rich motif (PSLP: residues 145–148) that can potentially interact with the SH3 domain. For confirmation, two proline residues in the PSLP motif were mutated to leucines, to produce PLD2 (P145L/P148L). This mutation did not change the expression level, the subcellular localization, or the catalytic properties of PLD2 in vitro (data not shown). COS-7 cells were transfected with the empty vector, PLD2 wild type, or PLD2 mutant. After immunoprecipitation with anti-PLD antibody and thorough washing, immune complexes were incubated with purified PLC-γ1. As shown in Fig. 4E, PLC-γ1 bound to PLD2 wild type but not to PLD2 mutant. These results strongly indicate that PLC-γ1 binds to PSLP motif within the PX domain of PLD2. It is generally known that the selectivity of the SH3 domains for their ligands is marginal (53Mayer B.J. J. Cell Sci. 2001; 114: 1253-1263Crossref PubMed Google Scholar). We tested whether the interaction between the SH3 domain of PLC-γ1 and the PX domain of PLD2 was specific or not. First, we performed in vitrobinding analysis with purified PLD2 and GST fusion SH3 domain of PLC-γ1, Abl, and CrkI and found that PLD2 binds strongly to the SH3 domain of PLC-γ1 but not to that of Abl or CrkI (Fig.5A). Second, we performedin vitro binding analysis with purified PLC-γ1 and the GST fusion PX domain of PLD2, p40phox, and p47phox and found that PLC-γ1 binds to the PX domain of PLD2 but not to the PX domain of p40phox or p47phox (Fig. 5B). These results indicate that the interaction between the SH3 domain of PLC-γ1 and the PX domain of PLD2 is specific. To identify the role of their interaction in EGF signaling, EGF-induced IP3 formation and Ca2+increase were measured after transfecting PLD2 wild type or PLD2 mutant (P145L/P148L) into COS-7 cells. EGF-induced IP3 formation and [Ca2+]i increase were potentiated in PLD2 wild type-transfected cells but not in PLD2 mutant-transfected cells (Fig. 6, A and B). The basal activities of PLD2 wild type and PLD2 mutant show no difference, but the EGF-induced activity of PLD2 mutant decreasedversus PLD2 wild type, indicating that PLC-γ1 activation is crucial for PLD2 activation in these cells (Fig. 6C), and PLC-γ1 bound only to PLD2 wild type and not to mutant after EGF stimulation (Fig. 6D). These results indicate that the interaction between PLC-γ1 and PLD2 may be important for EGF-induced IP3 formation and [Ca2+]iincrease. There remained a possibility that PLD2 might affect the tyrosine phosphorylation of PLC-γ1 to potentiate IP3formation and [Ca2+]i increase. To test this possibility, we checked the EGF-induced tyrosine phosphorylation of PLC-γ1 after transfecting PLD2 wild type or PLD2 mutant (P145L/P148L) into COS-7 cells. PLD2 transfection was found to have no effect on the EGF-induced tyrosine phosphorylation of PLC-γ1 (Fig.7). This result indicates that the potentiation of IP3 formation and Ca2+ increase is not due to the change of the tyrosine phosphorylation of PLC-γ1. In this study, we report for the first time upon the phospholipase complex of PLC-γ1 and PLD2. The communication between PLC-γ1 and PLD has been questioned because EGF stimulation activates PLC-γ1 and PLD2 both and because in each signaling pathway there are common molecules such as PKC and PIP2 (22Kim Y. Han J.M. Han B.R. Lee K.-A. Kim J.H. Lee B.D. Jang I.-H. Suh P.-G. Ryu S.H. J. Biol. Chem. 2000; 275: 13621-13627Abstract Full Text Full Text PDF PubMed Scopus (80) Google Scholar, 23Sciorra V.A. Rudge S.A. Prestwich G.D. Frohman M.A. Engebrecht J. Morris A.J. EMBO J. 1999; 18: 5911-5921Crossref PubMed Scopus (147) Google Scholar). PIP2, the substrate of PLC-γ1, was reported to be a cofactor for PLD activation (16Frohman M.A. Sung T.C. Morris A.J. Biochim. Biophys. Acta. 1999; 1439: 175-186Crossref PubMed Scopus (277) Google Scholar). It was also reported that PLC-γ1 influenced PLD activity through PKC, suggesting that PLC-γ1 might be an upstream regulator of PLD (26Hornia A. Lu Z. Sukezane T. Zhong M. Joseph T. Frankel P. Foster D.A. Mol. Cell. Biol. 1999; 19: 7672-7680Crossref PubMed Google Scholar, 33Hess J.A. Ji Q.-S. Carpenter G. Exton J.H. J. Biol. Chem. 1998; 273: 20517-20524Abstract Full Text Full Text PDF PubMed Scopus (24) Google Scholar, 54Slaaby R. Du G. Altshuller Y.M. Frohman M.A. Seedorf K. Biochem. J. 2000; 351: 613-619Crossref PubMed Scopus (37) Google Scholar). PA, the product of PLD action, increased PLC-γ1 activity in vitro (34Jones G.A. Carpenter G. J. Biol. Chem. 1993; 268: 20845-20850Abstract Full Text PDF PubMed Google Scholar). However, these were an indirect communications. In the present study, we found that PLC-γ1 binds directly to PLD2, which may provide a new perspective on the communication between PLC-γ1 and PLD. This interaction may increase the efficacy of their communication via other cellular components such as PIP2 and PKC, and the interaction itself may have an important role. In this report, we propose that PLD2 may function as an adaptor in the redistributing of PLC-γ1 to the membrane region. This is an as yet unidentified function of PLD2, and we suggest that PLD2 can function as an upstream regulator of PLC-γ1 in EGF signaling. Upon EGF stimulation, PLC-γ1 is recruited from the cytosol to the plasma membrane where EGF receptor is activated (29Jang I.-H. Kim J.H. Lee B.D. Bae S.S. Park M.H. Suh P.-G. Ryu S.H. FEBS Lett. 2001; 491: 4-8Crossref PubMed Scopus (37) Google Scholar), but how PLC-γ1 has access to PIP2 is not fully understood. In the recruitment of PLC-γ1, two SH2 domains of PLC-γ1 have reported to play critical roles (15Chattopadhyay A. Vecchi M. Ji Q.-S. Mernaugh R. Carpenter G. J. Biol. Chem. 1999; 274: 26091-26097Abstract Full Text Full Text PDF PubMed Scopus (115) Google Scholar). After being phosphorylated at tyrosine residues, PLC-γ1 is redistributed to its substrate-enriched region. We suggest that the SH3 domain of PLC-γ1 may contribute to the redistribution process. Little is known of the roles of the PLC-γ1 SH3 domain in EGF-induced PIP2 hydrolysis. Our findings suggest that the SH3 domain of PLC-γ1 may increase its substrate accessibility by bringing PLC-γ1 into the vicinity of PIP2. It was also reported that a PLC-γ1 mutant lacking the SH3 domain showed reduced membrane association and activity (55Debell K.E. Stoica B.A. Veri M.-C. Baldassarre A.D. Miscia S. Graham L.J. Rellahan B.L. Ishiai M. Kurosaki T. Bonvini E. Mol. Cell. Biol. 1999; 19: 7388-7398Crossref PubMed Google Scholar). The binding partner of the PLC-γ1 SH3 domain in the membrane, however, has not been identified. We found that PLD2 binds to the SH3 domain of PLC-γ1. PLD2 is a membrane protein and requires PIP2 for its activity, which means that PLD2 should be in the membrane region where PIP2 resides. Several reports show that PLD2 is mainly localized to the membrane substructure where PIP2 is enriched (25Xu L. Shen Y. Joseph T. Bryant A. Luo J.-O. Frankel P. Rotunda T. Foster D.A. Biochem. Biophys. Res. Commun. 2000; 273: 77-83Crossref PubMed Scopus (25) Google Scholar, 56Czarny M. Lavie Y. Fiucci G. Liscovitch M. J. Biol. Chem. 1999; 274: 2717-2724Abstract Full Text Full Text PDF PubMed Scopus (101) Google Scholar, 57Liscovitch M. Czarny M. Fiucci G. Lavie Y. Tang X. Biochim. Biophys. Acta. 1999; 1439: 245-263Crossref PubMed Scopus (136) Google Scholar). We suggest that PLD2 is the binding partner of the PLC-γ1 SH3 domain in its redistribution. Nevertheless, the SH3 domain may not be the only domain responsible for this redistribution, because the deletion of the SH3 domain did not result in the complete inhibition of PLC-γ1 activity (55Debell K.E. Stoica B.A. Veri M.-C. Baldassarre A.D. Miscia S. Graham L.J. Rellahan B.L. Ishiai M. Kurosaki T. Bonvini E. Mol. Cell. Biol. 1999; 19: 7388-7398Crossref PubMed Google Scholar). Membrane association was also facilitated by the interaction between the C-SH2 or the pleckstrin homology (PH) domain of PLC-γ1 and PIP3(58Falasca M. Logan S.K. Lehto V.P. Baccante G. Lemmon M.A. Schlessinger J. EMBO J. 1998; 17: 414-422Crossref PubMed Scopus (488) Google Scholar, 59Bae Y.S. Cantley L.G. Chen C.S. Kim S.R. Kwon K.S. Rhee S.G. J. Biol. Chem. 1998; 273: 4465-4469Abstract Full Text Full Text PDF PubMed Scopus (303) Google Scholar). Prevention of PIP3 generation by inhibiting phosphatidylinositol 3-kinase with wortmannin or LY294002 resulted in an ∼40% decrease in PLC activity (60Rameh L.E. Rhee S.G. Spokes K. Kazlauskas A. Cantley L.C. Cantley L.G. J. Biol. Chem. 1998; 273: 23750-23757Abstract Full Text Full Text PDF PubMed Scopus (205) Google Scholar). Considering our findings and those of previous studies, we suggest that the SH3 domain of PLC-γ1, together with the C-SH2 and the PH domain, play an important role in the redistribution of PLC-γ1 to increase its substrate accessibility. PLD2 has a region consisting of the PX and the PH domains whose exact roles have not been clarified. Our results demonstrate that PLC-γ1 binds directly to the PX domain of PLD2. This finding suggests that the PX domain of PLD2 serves as an adaptor for other proteins. In the 53-amino acid region responsible for PLC-γ1 binding (Fig.4D), there is a proline-rich, canonical SH3 domain binding motif. Mutating prolines in this motif to leucines abrogates interaction with PLC-γ1 (Fig. 4E). Although it cannot be said that this mutation has no effect on the conformation of PLD2 PX, it does not change the expression level, subcellular localization, or catalytic properties of PLD2 in vitro (data not shown). These results suggest that the effect of this mutation on the PLD2 structure, if any, is neither dramatic nor significant for the PLD2 function except for the PLC-γ1 interaction. Other proteins containing the SH3 domain may also use the PX domain of PLD2 as an adaptor, but it seems likely that the interaction is most specific to the PLC-γ1 SH3 domain (Fig. 5A). The specificity of the PX domains to bind PLC-γ1 has also been proven to be unique (Fig. 5B). Recently, it was reported that the PX domain of p47phox binds to its own C-terminal SH3 domain (69Hiroaki H. Ago T. Ito T. Sumimoto H. Kohda D. Nat. Struct. Biol. 2001; 8: 526-530Crossref PubMed Scopus (149) Google Scholar). Karathanassis et al.(70Karathanassis D. Stahelin R. Bravo J. Perisic O. Pacold C.M. Cho W. Williams R.L. EMBO J. 2002; 21: 5057-5068Crossref PubMed Scopus (262) Google Scholar) suggested that p47phox-PX would have to undergo a conformational change to interact with its C-SH3 domain. However, this prediction may not fit with PLD2-PX because PLC-γ1 does not interact with the p47phox-PX (Fig. 5B). The PX domain structure of PLD2 may not be exactly the same as that of p47phox. It is also known that PX domains bind to phosphoinositides and play critical roles in the intracellular localization of a variety of cell-signaling proteins, including p47phox and p40phox (61Sato T.K. Overduin M. Emr S.D. Science. 2001; 294: 1881-1885Crossref PubMed Scopus (205) Google Scholar). Because PLD binds to PIP2, requires PIP2 for enzymatic activity, and localizes in PIP2-enriched membranes (16Frohman M.A. Sung T.C. Morris A.J. Biochim. Biophys. Acta. 1999; 1439: 175-186Crossref PubMed Scopus (277) Google Scholar, 25Xu L. Shen Y. Joseph T. Bryant A. Luo J.-O. Frankel P. Rotunda T. Foster D.A. Biochem. Biophys. Res. Commun. 2000; 273: 77-83Crossref PubMed Scopus (25) Google Scholar), the PX domain of PLD may exist in proximity to PIP2. Considering our findings and previous studies, we suggest that the PX domain of PLD2 contributes to increasing the substrate accessibility of PLC-γ1 by functioning as an adaptor for its SH3 domain. The mechanism of the interaction between PLC-γ1 and PLD2 is the issue at question. We found that the interaction between PLC-γ1 and PLD2 is dependent on EGF stimulation and is transient (Fig. 2C). In the COS-7 cells, it was estimated that ∼0.5% of the total PLC-γ1 translocates to the caveolae after EGF stimulation (data not shown). This increases to 1% after PLD2 transfection. The co-immunoprecipitated PLC-γ1 almost equals this percentage. Without EGF stimulation, PLC-γ1 showed no interaction with PLD2; however, after EGF stimulation, PLC-γ1 bound to PLD2, and this interaction disappeared 1 min after EGF stimulation. We observed that the activity of PLC-γ1 after EGF stimulation was highest at around the time when PLC-γ1 interacts with PLD2 (Fig. 2B). Because the overexpression of PLD2 in COS-7 cells potentiates the EGF-induced IP3 formation and [Ca2+]i increase (Fig. 6, A and B), it is possible that PLD2 augments PLC-γ1 recruitment and its tyrosine phosphorylation. However, as shown in Fig. 7, PLD2 dose not affect PLC-γ1 tyrosine phosphorylation levels. PLD2 may contribute to bring PLC-γ1 to the proximity of PIP2, and PLC-γ1 may be redistributed to the membrane by binding with PLD2. Our findings show that the interaction between the SH3 domain of PLC-γ1 and the PX domain of PLD2 is important for EGF-induced Ca2+ signaling. These results also suggest that the signaling pathways of PLC-γ1 and PLD2 may cooperatively propagate. Cell proliferation plays a fundamental role in the development and maintenance of organisms. EGF is known to influence cell proliferation, and the EGF receptor is the receptor most often found to be up-regulated in a wide variety of human tumors (62Mendelsohn J. Endocr. Relat. Cancer. 2001; 8: 3-9Crossref PubMed Scopus (294) Google Scholar). Cell proliferation, however, requires the triggering of numerous downstream signaling pathways. These pathways include those that involve PLC-γ1 and its downstream Ca2+- and PKC-mediated cascades and PLD. In many tumors there is no increase in the number of EGF receptors but, rather, its signaling is up-regulated (63Wells A. Int. J. Biochem. Cell Biol. 1999; 31: 637-643Crossref PubMed Scopus (899) Google Scholar). The enzymatic activity of PLC-γ1 is required for EGF-induced cell cycle progression into the S phase (2Wang Z. Glück S. Zhang L. Morgan M.F. Mol. Cell. Biol. 1998; 18: 590-597Crossref PubMed Google Scholar). Furthermore, PLC-γ1 signaling is regarded as a convergence point for a number of motility- and/or invasion-inducing pathways in cancers (64Kassis J. Lauffenburger D.A. Turner T. Wells A. Semin. Caner Biol. 2001; 11: 105-117Crossref PubMed Scopus (149) Google Scholar). Evidence shows that PLC-γ1 and PLD2 are overexpressed in many cancers (65Noh D.Y. Lee Y.H. Kim S.S. Kim Y.I. Ryu S.H. Suh P.-G. Park J.-G. Cancer. 1994; 73: 36-41Crossref PubMed Scopus (91) Google Scholar, 66Chang J.-S. Noh D.Y. Park I.A. Kim M.J. Song H. Ryu S.H. Suh P.-G. Cancer Res. 1997; 57: 5465-5468PubMed Google Scholar, 67Zhao Y. Ehara H. Akao Y. Shamoto M. Nakagawa Y. Banno Y. Deguchi T. Ohishi N. Yagi K. Nozawa Y. Biochem. Biophys. Res. Commun. 2000; 278: 140-143Crossref PubMed Scopus (122) Google Scholar, 68Min D.S. Kwon T.K. Park W.-S. Chang J.-S. Park S.-K. Ahn B.-H. Ryoo Z.-Y. Lee Y.H. Lee Y.S. Rhie D.-J. Yoon S.-H. Hahn S.J. Kim M.-S. Jo Y.-H. Carcinogenesis. 2001; 22: 1641-1647Crossref PubMed Scopus (73) Google Scholar), and, in the present study, we found that the direct interaction between PLC-γ1 and PLD2 is important for EGF signaling. The possibility of the involvement of the coordination between PLC-γ1 and PLD2 in tumor cell mitogenesis or movement is an important issue for future studies.